1 1

Molfinity

Linzagolix - CAS 935283-04-8

Linzagolix - CAS 935283-04-8

MF-0006216-01

$36.16 USD
$22.75 USD $36.16 USD
Sale Sold out
Taxes included.
Size
View full details

Product Details

  • Bioactivity

    Linzagolix is a small-molecule, non-peptide, orally active gonadotropin-releasing hormone antagonist (GnRH antagonist) which is under development by Kissei Pharmaceutical and ObsEva for the treatment of uterine fibroids, endometriosis, and adenomyosis. As of December 2020, it is under review for approval for uterine fibroids, is in phase III clinical trials for endometriosis, and is in phase II clinical studies for adenomyosis.

  • Target

    GNRH Receptor

  • Related Pathways

    GPCR/G Protein

  • CAS Number

    935283-04-8

  • Purity

    0.9968

  • Molecular Formula

    C22H15F3N2O7S

  • Molecular Weight

    508.42

  • SMILES

    COc1cc(F)c(cc1OCc1c(OC)ccc(F)c1F)-n1c(=O)[nH]c2csc(C(O)=O)c2c1=O

  • Storage Temperature

    -20°C

  • Shipping Conditions

    Ice Packs

  • Category

    Small Compound